English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Poster

In silico optimization of iopamidol CEST MRI for renal pH mapping at 3 Tesla

MPS-Authors
/persons/resource/persons214560

Zaiss,  M       
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

External Resource

https://submissions.mirasmart.com/ISMRM2023/Itinerary/ConferenceMatrixEventDetail.aspx?ses=D-83
(Abstract)

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Stabinska, J., Zaiss, M., Bibic, A., Sedaghat, F., Sadowsky, C., van Zijl, P., et al. (2023). In silico optimization of iopamidol CEST MRI for renal pH mapping at 3 Tesla. Poster presented at 2023 ISMRM & ISMRT Annual Meeting & Exhibition (ISMRM 2023), Toronto, Canada.


Cite as: https://hdl.handle.net/21.11116/0000-000D-35AE-4
Abstract
In vivo optimization of CEST iopamidol contrast in human subjects is complicated and requires multiple examinations and injections of the agent. To address this challenge, we propose application of a numerical approach that utilizes exchange rates determined under physiological conditions at 17.6T to perform kidney-like multi-pool Bloch-McConnell simulations for in silico optimization of saturation parameters for 3T applications. Our results suggest that the iopamidol-based CEST MRI is sensitive to pH in the range between 6 and 7.2 with the optimal results when short CEST saturation pulses (3x100 ms), low B1 strength (B1~0.8 µT) and short recovery time (Trec~T1w) are applied.